Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1942073Generated: October 26, 2026

1-Piperazinecarboxamide → (rac)-4-{3-[1-(5,7-Difluoro-quinolin-6-yl)-ethyl]-imidazo[1,2-b]pyridazin-6-yl}-piperazine-1-carboxylic acid amide

https://huagongshe.com/reaction/1942073

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-PiperazinecarboxamideHCID 258192—
Reactant(Rac)-6-[1-(6-chloro-imidazo[1,2-b]pyridazin-3-yl)-ethyl]-5,7-difluoro-quinolineHCID 58147541—
Product(rac)-4-{3-[1-(5,7-Difluoro-quinolin-6-yl)-ethyl]-imidazo[1,2-b]pyridazin-6-yl}-piperazine-1-carboxylic acid amideHCID 50914628—

Reaction Steps

The title compound was prepared in analogy to Example 3 using (rac)-6-[1-(6-chloro-imidazo[1,2-b]pyridazin-3-yl)-ethyl]-5,7-difluoro-quinoline (Intermediate C) and piperazine-1-carboxamide instead of piperazin-2-one (tR 3.16 min (conditions 1), MH+=438, 1H-NMR in DMSO-d6: 8.95 (d, 1H); 8.46 (d, 1H); 7.80 (d, 1H); 7.65 (d, 1H); 7.61 (s, 1H); 7.60 (m, 1H); 7.08 (d, 1H); 6.07 (s, 2H); 4.98 (m, 1H); 3.15-3.40 (m, 8H); 1.88 (d, 3H)).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08389526B2
Source datasetuspto-grants-2013_03
ORD IDord-0e6d8ade794447ad8826fe57fb0d7f87
Source noteuspto-grants-2013_03